Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Mesenchymal stem cells have been recently described to localize to breast carcinomas, where they integrate into the tumour-associated stroma. However, the involvement of mesenchymal stem cells (or their derivatives) in tumour pathophysiology has not been addressed. Here, we demonstrate that bone-marrow-derived human mesenchymal stem cells, when mixed with otherwise weakly metastatic human breast carcinoma cells, cause the cancer cells to increase their metastatic potency greatly when this cell mixture is introduced into a subcutaneous site and allowed to form a tumour xenograft. The breast cancer cells stimulate de novo secretion of the chemokine CCL5 (also called RANTES) from mesenchymal stem cells, which then acts in a paracrine fashion on the cancer cells to enhance their motility, invasion and metastasis. This enhanced metastatic ability is reversible and is dependent on CCL5 signalling through the chemokine receptor CCR5. Collectively, these data demonstrate that the tumour microenvironment facilitates metastatic spread by eliciting reversible changes in the phenotype of cancer cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“MSC can be mobilized and recruited to active tumor sites, where they can incorporate into the tumor’s microenvironment [5, 68, 100–103].”
From Mesenchymal stem cell secretome and regenerative therapy after cancer (2013) · cites this paper as [100]
In the citing paper
“CCL5 can be secreted by both BM-MSC and ASC [100, 144] and displays pro-proliferative activities on breast cancer cell lines [145, 146].”
From Mesenchymal stem cell secretome and regenerative therapy after cancer (2013) · cites this paper as [100]
In the citing paper
“Another MSC-secreted pro-metastasis cytokine, CCL5 (RANTES), can be secreted upon interaction with cancer cells and is associated with tumor progression and invasion in various cancers [73, 87, 100, 142–144].”
From Mesenchymal stem cell secretome and regenerative therapy after cancer (2013) · cites this paper as [100]
In the citing paper
“The injection of bone marrow-derived MSCs into tumour-bearing mice has demonstrated that they can become CAFs40”
From A framework for advancing our understanding of cancer-associated fibroblasts (2020) · cites this paper as [40]
In the citing paper
“CAFs comprise the majority of cell types within the TME, and their reciprocal interactions with cancer cells have been well documented (Whiteside, 2008; Hazlehurst et al., 2003; Karnoub et al., 2007).”
From Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism (2016) · cites this paper as Karnoub et al., 2007
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Multilineage potential of adult human mesenchymal stem cells
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., & Marshak, D. R. (1999) · Science · doi:10.1126/science.284.5411.143 · Cited by 21,052
Epithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature Reviews Cancer · doi:10.1038/nrc822 · Cited by 6,628
Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Self-citationCreation of human tumour cells with defined genetic elements
Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W., & Weinberg, R. A. (1999) · Nature · doi:10.1038/22780 · Cited by 2,345
Self-citationCancer and the chemokine network
Balkwill, F. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1388 · Cited by 2,343
Bissell, M. J., & Radisky, D. (2001) · Nature Reviews Cancer · doi:10.1038/35094059 · Cited by 2,180
Molecular characterization of the tumor microenvironment in breast cancer
Allinen, M., Beroukhim, R., Cai, L., Brennan, C., Lahti-Domenici, J., Huang, H., Porter, D., Hu, M., Chin, L., Richardson, A., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.010 · Cited by 1,299
Self-citationHuman Bone Marrow–Derived Mesenchymal Stem Cells in the Treatment of Gliomas
Nakamizo, A., Marini, F., Amano, T., Khan, A., Studeny, M., Gumin, J., Chen, J., Hentschel, S., Vecil, G., Dembinski, J., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1874 · Cited by 1,035
(2002) · PubMed · Cited by 903
Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells
Elenbaas, B., Spirio, L., Koerner, F., Fleming, M. D., Zimonjic, D. B., Donaher, J. L., Popescu, N. C., Hahn, W. C., & Weinberg, R. A. (2001) · Genes & Development · doi:10.1101/gad.828901 · Cited by 878
Self-citation
Cited by
Items 701–800 of 1,024
Wang, W., Zhong, W., Yuan, J., Yan, C., Hu, S., Tong, Y., Mao, Y., Hu, T., Zhang, B., & Song, G. (2015) · Oncotarget · doi:10.18632/oncotarget.5514 · Cited by 92
“Many reports described that MSCs can home and engraft to different types of solid tumors, such as breast [10, 11], prostate [12], lung [13], and ovarian [14].”
BackgroundMesenchymal Stem Cells Induce Directional Migration of Invasive Breast Cancer Cells through TGF-β
McAndrews, K. M., McGrail, D. J., Ravikumar, N., & Dawson, M. R. (2015) · Scientific Reports · doi:10.1038/srep16941 · Cited by 89
Shin, S. Y., Nam, J., Lim, Y., & Lee, Y. H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.128124 · Cited by 104
Xu, S., Menu, E., Becker, A. D., Van Camp, B., Vanderkerken, K., & Van Riet, I. (2012) · Stem Cells · doi:10.1002/stem.787 · Cited by 103
Therapeutic Efficacy and Fate of Bimodal Engineered Stem Cells in Malignant Brain Tumors
Martínez‐Quintanilla, J., Bhere, D., Heidari, P., He, D., Mahmood, U., & Shah, K. (2013) · Stem Cells · doi:10.1002/stem.1355 · Cited by 103
Chemokine Receptor Signaling and the Hallmarks of Cancer
Lacalle, R. A., Blanco, R., Carmona‐Rodríguez, L., Martín‐Leal, A., Mira, E., & Mañes, S. (2016) · International review of cytology · doi:10.1016/bs.ircmb.2016.09.011 · Cited by 103
Mesenchymal Stem Cells in Cancer
Stagg, J. (2008) · Stem Cell Reviews and Reports · doi:10.1007/s12015-008-9030-4 · Cited by 103
“In human breast cancer, human MSCs have been shown to migrate up to 11fold more towards conditioned media from cancer cells than from non cancer cells [ 20 ].”
BackgroundMethodInfluentialRhodes, L. V., Antoon, J. W., Muir, S. E., Elliott, S., Beckman, B. S., & Burow, M. E. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-295 · Cited by 101
“have demonstrated the ability of hMSCs to confer a metastatic phenotype to normally non/low metastatic cancer cells [49].”
BackgroundInfluentialBone marrow as a metastatic niche for disseminated tumor cells from solid tumors
Shiozawa, Y., Eber, M. R., Berry, J. E., & Taichman, R. S. (2015) · BoneKEy Reports · doi:10.1038/bonekey.2015.57 · Cited by 102
Contributions of the Host Microenvironment to Cancer-Induced Bone Disease
Olechnowicz, S. W. Z., & Edwards, C. M. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2645 · Cited by 102
Klotho is silenced through promoter hypermethylation in gastric cancer.
Wang, L., Wang, X., Wang, X., Pan, J., Lu, H., Zhang, S., Lin, X., Lam, E. K. Y., Cui, Y., Yu, J. Q., et al. (2011) · Europe PMC (PubMed Central) · Cited by 102
Cancer Associated Fibroblasts and Tumor Growth: Focus on Multiple Myeloma
Veirman, K. D., Rao, L., Bruyne, E. D., Menu, E., Valckenborgh, E. V., Riet, I. V., Frassanito, M. A., Marzo, L. D., Vacca, A., & Vanderkerken, K. (2014) · Cancers · doi:10.3390/cancers6031363 · Cited by 102
“chemotactic properties secreted by CAFs Karnoub and colleagues reported that in breast cancer CCL5 is involved in metastasis formation [63].”
BackgroundMesenchymal stem cells in the tumor microenvironment
GUAN, J., & Chen, J. (2013) · Biomedical Reports · doi:10.3892/br.2013.103 · Cited by 102
Induction of Bv8 Expression by Granulocyte Colony-stimulating Factor in CD11b+Gr1+ Cells
Qu, X., Zhuang, G., Yu, L., Meng, G., & Ferrara, N. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.326801 · Cited by 90
Eck, S. M., Côté, A. L., Winkelman, W. D., & Brinckerhoff, C. E. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0015 · Cited by 88
“cells depend on stromal cells to metastasize (7).”
Patel, A. K., Vipparthi, K., Thatikonda, V., Arun, I., Bhattacharjee, S., Sharan, R., Arun, P., & Singh, S. (2018) · Oncogenesis · doi:10.1038/s41389-018-0087-x · Cited by 93
Chen, J., Ji, T., Wu, D., Shi, J., Zhao, J., Lin, H. M., & Cai, X. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1622-1 · Cited by 101
Mesenchymal Stem/Stromal Cell Engulfment Reveals Metastatic Advantage in Breast Cancer
Chen, Y., González, M. E., Burman, B., Zhao, X., Anwar, T., Tran, M., Medhora, N., Hiziroglu, A. B., Lee, W., Cheng, Y.-H., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.05.084 · Cited by 101
“MSCs are recruited to the primary tumor site from the bone marrow in response to soluble factors derived from the tumor cells and have been shown to promote breast cancer progression (Berger et al., 2016; El-Haibi et al., 2012; Kalluri and Zeisberg, 2006; Karnoub et al., 2007; Liu et al., 2011; Madar et al., 2013).”
BackgroundKoopman, M., Venderbosch, S., van Tinteren, H., Ligtenberg, M. J. L., Nagtegaal, I. D., van Krieken, J. H., & Punt, C. J. A. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.04.017 · Cited by 101
Kučerová, L., Miklikova, S., Matúšková, M., Boháč, M., & Kozovská, Z. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-535 · Cited by 102
“The interaction of BM-MSCs and breast cancer cells was also shown to promote metastatic spread as a result of bidirectional paracrine signaling [17].”
BackgroundWnt3a signaling within bone inhibits multiple myeloma bone disease and tumor growth
Qiang, Y.-W., Shaughnessy, J. D., & Yaccoby, S. (2008) · Blood · doi:10.1182/blood-2007-10-120253 · Cited by 95
“However, it is now well recognized that an interaction of tumors with their associated stroma can dramatically influence tumor behavior.(38) Therefore, it is feasible that activation of the Wnt signaling pathway in the tumor-stroma milieu might override presumed proliferative effects of activating that signaling pathw…”
BackgroundMesenchymal stem cell signaling in cancer progression
Torsvik, A., & Bjerkvig, R. (2013) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.03.005 · Cited by 100
The Bone Marrow Microenvironment as Niche Retreats for Hematopoietic and Leukemic Stem Cells
Nwajei, F., & Konopleva, M. Y. (2013) · Advances in Hematology · doi:10.1155/2013/953982 · Cited by 100
Perspectives for Clinical Translation of Adipose Stromal/Stem Cells
Patrikoski, M., Mannerström, B., & Miettinen, S. (2019) · Stem Cells International · doi:10.1155/2019/5858247 · Cited by 100
Miyazaki, Y., Oda, T., Mori, N., & Kida, Y. S. (2020) · FEBS Open Bio · doi:10.1002/2211-5463.12976 · Cited by 86
Implications for human adipose‐derived stem cells in plastic surgery
Banyard, D. A., Salibian, A. A., Widgerow, A. D., & Evans, G. R. D. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12425 · Cited by 100
“For example, studies have demonstrated that MSCs potentiate the metastatic potency of breast cancer cells when the two are mixed and reimplanted [41–43].”
Chemokine C‐C motif receptor 5 and C‐C motif ligand 5 promote cancer cell migration under hypoxia
Lin, S., Wan, S., Sun, L., Hu, J., Fang, D., Zhao, R., Yuan, S., & Zhang, L. (2012) · Cancer Science · doi:10.1111/j.1349-7006.2012.02259.x · Cited by 92
Rappa, G., Mercapide, J., & Lorico, A. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.02.020 · Cited by 99
Babajani, A., Soltani, P., Jamshidi, E., Farjoo, M. H., & Niknejad, H. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00748 · Cited by 99
Potential implications of mesenchymal stem cells in cancer therapy
Dai, L.-J., Moniri, M. R., Zeng, Z.-R., Zhou, J. X., Rayat, J., & Warnock, G. L. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.02.012 · Cited by 99
“Similar observation was also reported in breast subcutaneous tumor model [63] and other types of cancer studies, such as ovarian cancer [64] and gastric cancer [65].”
ResultMesenchymal stem cells enhance lung cancer initiation through activation of IL-6/JAK2/STAT3 pathway
Hsu, H., Lin, J.-H., Hsu, T.-W., Su, K., Wang, C.-W., Yang, K., Chiou, S., & Hung, S. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2011.07.001 · Cited by 99
“[5] demonstrated that bone-marrow-derived human MSCs, when mixed with human breast carcinoma cells, can cause the cancer cells to greatly increase their metastatic potential.”
BackgroundRecapitulating the Size and Cargo of Tumor Exosomes in a Tissue-Engineered Model
Villasante, A., Marturano-Kruik, A., Ambati, S. R., Liu, Z., Godier-Furnemont, A., Parsa, H., Lee, B. W., Moore, M. A. S., & Vunjak-Novakovic, G. (2016) · Theranostics · doi:10.7150/thno.13944 · Cited by 92
“MSC can be recruited in large numbers to the tumor stroma, to enhance tumor growth and metastasis [52].”
Pietrovito, L., Leo, A., Gori, V., Lulli, M., Parri, M., Becherucci, V., Piccini, L., Bambi, F., Taddei, M. L., & Chiarugi, P. (2018) · Molecular Oncology · doi:10.1002/1878-0261.12189 · Cited by 100
“This observation is in agreement with data showing that cytokines secreted by BM-MSCs not previously in contact with cancer cells, can directly support proliferation and migration of tumour cells (Karnoub et al., 2007; Martin et al., 2010; Tsai et al., 2011; Xu et al., 2009).”
BackgroundResultvon Einem, J. C., Guenther, C., Volk, H., Grütz, G., Hirsch, D., Salat, C., Stoetzer, O., Nelson, P. J., Michl, M., Modest, D. P., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32230 · Cited by 93
Mesenchymal Stem Cells: New Approaches for the Treatment of Neurological Diseases
Momin, E. N., Mohyeldin, A., Zaidi, H. A., Vela, G., & Quiñones‐Hinojosa, A. (2010) · Current Stem Cell Research & Therapy · doi:10.2174/157488810793351631 · Cited by 99
“MSCs have also been shown to increase the metastatic potential of breast cancer cell lines [85].”
BackgroundLong, H., Xiang, T., Qi, W., Huang, J., Chen, J., He, L., Liang, Z., Guo, B., Li, Y., Xie, R., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3462 · Cited by 98
“CCL5 produced by MSCs within the tumor stroma plays a crucial role in breast cancer cell invasion [24].”
InfluentialStem cell technology for bone regeneration: current status and potential applications
Asatrian, G., Pham, D., Hardy, W. R., James, A. W., & Péault, B. (2015) · Stem Cells and Cloning Advances and Applications · doi:10.2147/sccaa.s48423 · Cited by 100
Roles of Oncogenic Long Non-coding RNAs in Cancer Development
Do, H., & Kim, W. (2018) · Genomics & Informatics · doi:10.5808/gi.2018.16.4.e18 · Cited by 99
The Epithelial-to-Mesenchymal Transition in Development and Cancer
Francou, A., & Anderson, K. V. (2019) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030518-055425 · Cited by 98
“In this collective invasion process, nonmalignant mesenchymal stem cells in the stroma surrounding the tumor participate in metastasis, enhancing cancer cells’ motility and invasion by secreting chemokines (Karnoub et al. 2007).”
Molecular Pathways: Trafficking of Metabolic Resources in the Tumor Microenvironment
Romero, I. L., Mukherjee, A., Kenny, H. A., Litchfield, L. M., & Lengyel, E. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2198 · Cited by 92
Koopman, M., Venderbosch, S., Nagtegaal, I. D., van Krieken, J. H., & Punt, C. J. A. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.04.023 · Cited by 98
Tumor Lymphangiogenesis as a Potential Therapeutic Target
Duong, T., Koopman, P. A., & François, M. (2012) · Journal of Oncology · doi:10.1155/2012/204946 · Cited by 98
“Importantly, MSCs infiltrate tumors in high number and have been shown to enhance breast cancer cell metastasis [169].”
BackgroundFgf9 signaling regulates small intestinal elongation and mesenchymal development
Geske, M. J., Zhang, X., Patel, K. K., Ornitz, D. M., & Stappenbeck, T. S. (2008) · Development · doi:10.1242/dev.020453 · Cited by 85
“For example, it has been recently shown that MSCs have the potential to play a role in disease by functioning as a nidus of paracrine signaling (Gnecchi et al., 2006; Karnoub et al., 2007).”
BackgroundCell communication networks in cancer invasion
Calvo, F., & Sahai, E. A. (2011) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2011.04.010 · Cited by 101
Paracrine effects of stem cells in wound healing and cancer progression
Dittmer, J., & Leyh, B. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2385 · Cited by 98
“Recently, ovarian CSCs have been reported to release CCL5 into the culture medium (102), a chemokine known to play a role in breast cancer metastasis and whose secretion can be triggered by co-culturing breast cancer cells with mesenchymal stem cells (103).”
BackgroundMaby-El Hajjami, H., Amé-Thomas, P., Pangault, C., Tribut, O., DeVos, J., Jean, R., Bescher, N., Monvoisin, C., Dulong, J., Lamy, T., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3000 · Cited by 85
“Second, MSCs could integrate the specialized tumor niche where they contribute to the development of tumor-associated fibroblasts, stimulate angiogenesis, and promote malignant cell growth, cancer metastasis (6, 7), and drug resistance.”
BackgroundShen, H., Yu, X., Yang, F., Zhang, Z., Shen, J., Sun, J., Choksi, S., Jitkaew, S., & Shu, Y. (2016) · PLOS Genetics · doi:10.1371/journal.pgen.1006244 · Cited by 91
“The expression levels of VEGFA, SDF-1, CCL2, CCL5 and MMP9 in tumors.”
BackgroundMethodInfluentialCCL5 as an adjuvant for cancer immunotherapy
Lapteva, N., & Huang, X. F. (2010) · Expert Opinion on Biological Therapy · doi:10.1517/14712591003657128 · Cited by 97
“Therefore, CCR5 displays an antagonistic function in regulation of tumor development: activating functional p53 to suppress tumor malignancy, but also inducing p53 mutations to abolish the p53-mediated tumor suppression [49].”
BackgroundInfluentialMesenchymal stem cell-secreted soluble signaling molecules potentiate tumor growth
Zhu, W., Huang, L., Li, Y., Qian, H., Shan, X., Yan, Y., Mao, F., Wu, X., & Xu, W. (2011) · Cell Cycle · doi:10.4161/cc.10.18.17638 · Cited by 97
Mouse models for breast cancer metastasis
Kim, I. S., & Baek, S. H. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.03.070 · Cited by 99
Spaeth, E. L., LaBaff, A. M., Toole, B. P., Klopp, A. H., Andreeff, M., & Marini, F. C. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0087 · Cited by 97
“Regardless of their origin, we and others have shown the protumorigenic (4, 12, 13) and prometastatic (14) effects of these stromal cells within the tumor microenvironment.”
BackgroundMolecular Oncology of Breast Cancer
Joshi, H. N., & Press, M. F. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35955-9.00022-2 · Cited by 100
Compte, M., Cuesta, Á. M., Sánchez-Martín, D., Alonso-Camino, V., Vicario, J. L., Sanz, L., & Álvarez-Vallina, L. (2009) · Stem Cells · doi:10.1634/stemcells.2008-0831 · Cited by 96
FOXF1 mediates mesenchymal stem cell fusion-induced reprogramming of lung cancer cells
Wei, H.-J., Nickoloff, J. A., Chen, W.-H., Liu, H., Lo, W., Chang, Y.-T., Yang, P., Wu, C., Williams, D. F., Gelovani, J. G., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2413 · Cited by 96
“Upon homing to the tumor lesions, MSCs reveal many promoting and supporting effects on tumor progression, including immune response suppression [20], enhancement of tumor growth [21–22], metastasis [17, 23] and stroma development [14], and regulation of cancer stem cell population [24–25].”
BackgroundTreg–tissue cell interactions in repair and regeneration
Loffredo, L. F., Savage, T. M., Ringham, O. R., & Arpaia, N. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20231244 · Cited by 96
Multipotent mesenchymal stromal cell therapy in renal disease and kidney transplantation
Reinders, M. E. J., Fibbe, W. E., & Rabelink, T. J. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp552 · Cited by 96
“Indeed, reports showed that MSCs can stimulate the growth of cancers [80] and promote metastasis in mice [81].”
BackgroundRegenerative therapy after cancer: what are the risks?
Donnenberg, V. S., Zimmerlin, L., Rubin, J. P., & Donnenberg, A. D. (2010) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2010.0352 · Cited by 95
“Like BM-MSC, ASC are able to give rise to differentiated progeny with characteristics of bone, cartilage, fat, and vessels and, like MSC, were predominantly CD105 þ /CD73 þ /CD90 þ /CD44 þ (Table 1).”
InfluentialInvolvement of Cyr61 in growth, migration, and metastasis of prostate cancer cells
Sun, Z.-J., Wang, Y., Cai, Z., Chen, P.-P., Tong, X.-J., & Xie, D. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604712 · Cited by 95
“Recently, Karnoub et al (2007) reported that stromal expression of CTGF promoted angiogenesis and tumorigenesis of PCa.”
Tu, B., Zhu, J., Liu, S., Wang, L., Fan, Q., Hao, Y., Fan, C., & Tang, T.-T. (2016) · Oncotarget · doi:10.18632/oncotarget.10219 · Cited by 95
“found that co-injection of human breast cancer cells with MSCs increased the metastasis of tumor cells [28].”
BackgroundMesenchymal Stem/Stromal Cells in Stromal Evolution and Cancer Progression
Cammarota, F., & Laukkanen, M. O. (2015) · Stem Cells International · doi:10.1155/2016/4824573 · Cited by 96
Wang, X., Liu, J., Wang, Z., Huang, Y., Liu, W., Zhu, X., Cai, Y., Fang, X., Lin, S., Yuan, L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072962 · Cited by 90
“MSCs can specifically migrate to and engraft at tumor sites and become a part of the tumor microenvironment, where they enhance the growth of the primary tumor and facilitate metastatic dissemination to distant organs [27,32,33,34].”
BackgroundCamorani, S., Hill, B. S., Fontanella, R., Greco, A., Gramanzini, M., Auletta, L., Gargiulo, S., Albanese, S., Lucarelli, E., Cerchia, L., et al. (2017) · Theranostics · doi:10.7150/thno.18974 · Cited by 95
“Recent evidences have widely shown that BM-MSCs can integrate into the tumor-associated stroma and promote the progression of TNBC through the activation of different mechanisms involving HIFs [14], TGF-β [13] and CCL5 [2].”
BackgroundResultInfluentialÖstman, A. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.09.022 · Cited by 96
Chao, K., Yang, H., & Chen, M. (2012) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01459.x · Cited by 95
“Generally, HBMSCs are considered to enhance tumourigenesis since they are a source of carcinoma-associated fibroblasts [13], they help to establish a microenvironment contributory to tumour growth, and they increase the metastatic potency of breast cancer cells [14].”
BackgroundNishimura, K., Semba, S., Aoyagi, K., Sasaki, H., & Yokozaki, H. (2012) · Pathobiology · doi:10.1159/000337296 · Cited by 85
Wendt, M. K., Schiemann, B. J., Parvani, J. G., Lee, Y.-H., Kang, Y., & Schiemann, W. P. (2012) · Oncogene · doi:10.1038/onc.2012.230 · Cited by 94
Liew, L. C., Katsuda, T., Gailhouste, L., Nakagama, H., & Ochiya, T. (2017) · International Immunology · doi:10.1093/intimm/dxx002 · Cited by 89
Multi‑faceted role of cancer‑associated adipocytes in the tumor microenvironment (Review)
Yao, H., & He, S. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.12506 · Cited by 94
“…ccl5, il‑1 β , il‑6, TnF α , VEGF and leptin, compared with relatively normal adipocytes (37), which can promote tumor invasion and metastasis (40,103). caas can also promote tumor growth and metastasis, compared with distant mature adipocytes, through fewer physical barriers (such as thickness…”
InfluentialYang, Y., Otte, A., & Hass, R. (2015) · Stem Cells and Development · doi:10.1089/scd.2014.0413 · Cited by 82
“Furthermore, these findings are substantiated by a previous work demonstrating enhanced tumor cell growth by MSC [34–37], although there are also controversial studies suggesting a reduced tumor cell proliferation in the presence of MSC [38,39].”
Chemokine signaling in cancer: Implications on the tumor microenvironment and therapeutic targeting.
Hembruff, S. L., & Cheng, N. (2009) · PubMed · Cited by 96
Kang, N.-H., Hwang, K.-A., Kim, S. U., Kim, Y.-B., Hyun, S., Jeung, E.-B., & Choi, K.-C. (2012) · Cancer Gene Therapy · doi:10.1038/cgt.2012.30 · Cited by 94
GPER-mediated proliferation and estradiol production in breast cancer-associated fibroblasts
Luo, H., Yang, G., Yu, T., Luo, S., Wu, C., Sun, Y., Liu, M., & Tu, G. (2014) · Endocrine Related Cancer · doi:10.1530/erc-13-0237 · Cited by 94
“R e la te d C a n ce r (Karnoub et al. 2007).”
BackgroundXie, C., Yang, Z., Suo, Y., Chen, Q., Wei, D., Weng, X., Gu, Z., & Wei, X. (2017) · Stem Cells Translational Medicine · doi:10.1002/sctm.16-0204 · Cited by 94
Stem cells from adipose tissue and breast cancer: hype, risks and hope
Bertolini, F., Petit, J.-Y., & Kolonin, M. G. (2015) · British Journal of Cancer · doi:10.1038/bjc.2014.657 · Cited by 93
“Stem cells from adipose tissue and breast cancer: hype, risks and hope”
BackgroundInfluentialKirchhammer, N., Trefny, M. P., Natoli, M., Brücher, D., Smith, S. N., Werner, F., Koch, V., Schreiner, D., Bartoszek, E. M., Buchi, M., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abm9043 · Cited by 93
“A number of studies suggest that CCL5 has potential tumor-promoting effects, either by directly affecting tumor growth ( 59 ), fostering an immunosuppressive tumor microenvironment ( 60 ), enhancing tumor cell migration ( 61 ), or expanding cancer stem cells ( 62 ).”
BackgroundWang, K., Eguiluz, R. C. A., Wu, F., Seo, B. R., Fischbach, C., & Gourdon, D. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.03.019 · Cited by 95
A “latent niche” mechanism for tumor initiation
McGovern, M., Voutev, R., Maciejowski, J., Corsi, A. K., & Hubbard, E. J. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903768106 · Cited by 93
Liu, X., Wu, M., Peng, Y., Chen, X., Sun, J., Huang, F., Fan, Z., Zhou, H., Wu, X., Yu, G., et al. (2013) · Cell Transplantation · doi:10.3727/096368912x661319 · Cited by 93
Sung, S.-Y., Liao, C., Wu, H.-P., Hsiao, W., Wu, I.-H., Jin-Pu, Yu, Lin, S.-H., & Hsieh, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071637 · Cited by 93
“Many observations indicate that, in the tumor microenvironment, MSCs have several tumor growth promoting functions, including the expression of growth factors [28], promotion of tumor vessel formation [29] and creation of cancer stem cell niches [30].”
BackgroundSpleens of myelofibrosis patients contain malignant hematopoietic stem cells
Wang, X., Prakash, S., Lu, M., Tripodi, J., Ye, F., Najfeld, V., Li, Y., Schwartz, M., Weinberg, R., Roda, P., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci64397 · Cited by 87
“The possible contribution of marrow-derived mesenchymal stem cells to tumor microenvironments has been previously reported by others (12–14).”
Self-citationSoria, G., Yaal-Hahoshen, N., Azenshtein, E., Shina, S., Leider-Trejo, L., Ryvo, L., Cohen-Hillel, E., Shtabsky, A., Ehrlich, M., Meshel, T., et al. (2008) · Cytokine · doi:10.1016/j.cyto.2008.08.002 · Cited by 92
Eiró, N., Sendon-Lago, J., Seoane, S., Bermúdez, M. A., Lamelas, M. L., Garcia-Caballero, T., Schneider, J., Perez-Fernandez, R., & Vizoso, F. J. (2014) · Oncotarget · doi:10.18632/oncotarget.2530 · Cited by 92
“The method for obtaining hUCESCs (Pap cervical smear) is much less invasive and painful that those used to obtain cervical MSCs (biopsy or hysterectomy) or other MSCs (from the bone marrow or adipose tissue).”
InfluentialMa, X., Wang, M., Yin, T., Zhao, Y., & Wei, X. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00855 · Cited by 92
“The tumor environment has been reported to play a key role in promoting metastases in patients with solid tumors (7).”
BackgroundMesenchymal Stem Cells Beyond Regenerative Medicine
Shammaa, R., El-Kadiry, A. E.-H., Abusarah, J., & Rafei, M. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00072 · Cited by 93
“Other challenges in MSC-based anticancer treatment are, paradoxically, cancer enhancement (Karnoub et al., 2007) even with induced anti-tumor immunity (vaccination) (Krampera et al.”
BackgroundObesity and prostate cancer — microenvironmental roles of adipose tissue
Saha, A., Kolonin, M. G., & DiGiovanni, J. (2023) · Nature Reviews Urology · doi:10.1038/s41585-023-00764-9 · Cited by 92
The role of stromal cells in the persistence of chronic inflammation
Naylor, A. J., Filer, A. D., & Buckley, C. D. (2012) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2012.04634.x · Cited by 99
Adipose tissue-derived progenitor cells and cancer
Zhang, Y. (2010) · World Journal of Stem Cells · doi:10.4252/wjsc.v2.i5.103 · Cited by 87
Buraschi, S., Neill, T., Owens, R. T., Iniguez, L. A., Purkins, G., Vadigepalli, R., Evans, B. J., Schaefer, L., Peiper, S. C., Wang, Z., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045559 · Cited by 92
An Inducible Caspase 9 Suicide Gene to Improve the Safety of Mesenchymal Stromal Cell Therapies
Ramos, C. A., Asgari, Z., Liu, E., Yvon, E. S., Heslop, H. E., Rooney, C. M., Brenner, M. K., & Dotti, G. (2010) · Stem Cells · doi:10.1002/stem.433 · Cited by 92
Integrated Akt/PKB Signaling in Immunomodulation and Its Potential Role in Cancer Immunotherapy
Xue, G., Zippelius, A., WICKI, A. N., Mandalà, M., Tang, F., Massi, D., & Hemmings, B. A. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv171 · Cited by 92
“In a xenograft model of breast cancer, CCL5 secreted from mesenchymal stem cells activated PKB signaling in circulating tumor cells to promote extravasation from the circulation and colonization at distal organs (120).”
BackgroundTargeting therapy-resistant cancer stem cells by hyperthermia
Oei, A. L., Vriend, L. E. M., Krawczyk, P. M., Horsman, M. R., Franken, N. A. P., & Crezee, J. (2017) · International Journal of Hyperthermia · doi:10.1080/02656736.2017.1279757 · Cited by 92
“negatively prognostic for overall survival [9,10], there is an”
BackgroundOvarian Carcinoma-Associated Mesenchymal Stem Cells Arise from Tissue-Specific Normal Stroma
Coffman, L. G., Pearson, A. T., Frisbie, L. G., Freeman, Z., Christie, E., Bowtell, D. D., & Buckanovich, R. J. (2019) · Stem Cells · doi:10.1002/stem.2932 · Cited by 86
Mesenchymal stromal cells: a key player in ‘innate tolerance’?
Dazzi, F., Lopes, L. M., & Weng, L. (2012) · Immunology · doi:10.1111/j.1365-2567.2012.03621.x · Cited by 92
Warfel, N. A., & Newton, A. C. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.r111.318675 · Cited by 91
Cheng, S., Nethi, S. K., Rathi, S., Layek, B., & Prabha, S. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.259796 · Cited by 91
“…from MSCs have been shown to contain tumor-supportive proteins such as platelet-derived growth factor receptor-b, tissue inhibitor of metalloproteinase-1, etc. (Djouad et al., 2003, 2006; Zhu et al., 2006; Karnoub et al., 2007; Muehlberg et al., 2009; Vallabhaneni et al., 2015; Lee and Hong, 2017).”
BackgroundRole of Patient-Derived Models of Cancer in Translational Oncology
Idrisova, K., Simon, H., & Gomzikova, M. O. (2022) · Cancers · doi:10.3390/cancers15010139 · Cited by 93
Adipose tissue cells, lipotransfer and cancer: A challenge for scientists, oncologists and surgeons
Bertolini, F., Lohsiriwat, V., Petit, J., & Kolonin, M. G. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.04.004 · Cited by 91
Homing of Cancer Cells to the Bone
Mishra, A., Shiozawa, Y., Pienta, K. J., & Taichman, R. S. (2011) · Cancer Microenvironment · doi:10.1007/s12307-011-0083-6 · Cited by 91
“Recent work has shown that exogenously administered mesenchymal-stem cells (MSCs) can enter the tumor stroma and promote metastasis in human breast carcinoma cells [32].”
BackgroundFenton, J. I., Nuñez, N. P., Yakar, S., Perkins, S. N., Hord, N. G., & Hursting, S. D. (2009) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00974.x · Cited by 87
Lin, J., Wang, J., Chen, M., Chen, H.-C., Chang, T.-H., Su, B.-W., & Chang, P. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.06.003 · Cited by 91
Metadata
- Authors
- Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., & Weinberg, R. A.
- Affiliations
- Whitehead Institute for Biomedical Research (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Weinberg, Robert A.
- Venue
- Nature
- Published
- 2007-10-04
- Volume
- 449
- Issue
- 7162
- Pages
- 557-563
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2141815918
- Cited by
- 3,206
- References
- 36
- Citations by year
- 2026: 41 · 2025: 69 · 2024: 95 · 2023: 137 · 2022: 144 · 2021: 186 · 2020: 192 · 2019: 153 · 2018: 145 · 2017: 176 · 2016: 182 · 2015: 222 · 2014: 232 · 2013: 232 · 2012: 216
- FWCI
- 89.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Cancer Institute (P50CA089393, R01CA116235)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Keywords
- mesenchymal stem cells, breast cancer metastasis, tumor stroma, RANTES, CCR5, paracrine signaling, tumor cell motility, tumor invasion, tumor microenvironment, bone marrow-derived stem cells, tumor xenografts
- MeSH terms
- Animals, Breast Neoplasms, Cell Movement, Fibroblasts, Humans, Lung Neoplasms, Neoplasm Invasiveness, Neoplasm Metastasis, Neoplasm Transplantation, Mice, SCID, Mice, Inbred NOD, Stromal Cells, Carcinoma, Ductal, Breast, Chemokine CCL5, Receptors, CCR5, Chemokines, CC, Paracrine Communication, Mesenchymal Stem Cell Transplantation, Cell Line, Tumor, Mice, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.